Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Biochem Pharmacol. 2021 Feb 10;186:114462. doi: 10.1016/j.bcp.2021.114462

Figure 8.

Figure 8.

Model for reinforced HIV latency following compound withdrawal. A, Summary of bioactivities of compounds described here. B, CDK9 inhibition inhibits spontaneous provirus expression and reinforces HIV latency even following compound withdrawal. However, ability to reinforce latency is sensitive to and prevented by simultaneous HDAC inhibition.